The expression of MMP1, a matrix metalloproteinase involved in cancer progression through degradation of the extracellular matrix39, was predicted to have an effect on the activity of the FOS TF (Fig. 4e, Supplementary Fig. S18g, h). The gene discussed is FOS; the disease is cancer.